Stock 2269 WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:20 26/04/2024 pm IST 		5-day change 1st Jan Change
13.48 HKD +5.81% Intraday chart for WuXi Biologics (Cayman) Inc. +6.81% -54.46%
01/04 Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer CI
27/03 WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump MT

Chart calendar WuXi Biologics (Cayman) Inc.

b48f0f4ef5667a14f3ea.E4W8BP3Kb8ByCK9BTj-LRxtoFhOW1jCpSdF27cs_ZL4.INSRfI-eNvMnbsp1e2qzfywZXVvJnwTMPZZAjIUSC-pi0PlGl4EpqzFQ2A~216a5a7957639cbe66e4f29aceea5b31

Upcoming events on WuXi Biologics (Cayman) Inc.

19/08/2024 Q2 2024 Earnings Release (Projected)
25/03/2025 Q4 2024 Earnings Release (Projected)
25/08/2025 Q2 2025 Earnings Release (Projected)
24/03/2026 Q4 2025 Earnings Release (Projected)

Past events on WuXi Biologics (Cayman) Inc.

27/03/2024 06:00 pm Q4 2023 Earnings Call
26/03/2024 Q4 2023 Earnings Release
10/01/2024 UBS Greater China Conference
08/01/2024 JPMorgan Healthcare Conference
04/01/2024 Morgan Stanley China New Economy Summit
23/08/2023 09:30 am Q2 2023 Earnings Call
23/08/2023 Q2 2023 Earnings Release
27/06/2023 07:30 am Annual General Meeting
20/06/2023 06:30 am Investor Day
01/06/2023 J.P. Morgan Global China Summit
18/05/2023 Citi APAC Healthcare Conference
09/05/2023 Macquarie DELTAH China Conference
22/03/2023 Q4 2022 Earnings Release
13/01/2023 UBS Greater China Conference
11/01/2023 11:15 pm J.P. Morgan Healthcare Conference
05/01/2023 Morgan Stanley Virtual China Opportunity Conference
26/09/2022 07:00 am J.P. Morgan Global Healthcare Shanghai Conference
17/08/2022 Interim 2022 Earnings Release
22/03/2022 FY 2021 Earnings Call - Slides
22/03/2022 FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million CNY		Released
Forecast
Spread 		2 535
2 518
0.66%		3 984
3 870
2.93%		5 612
5 491
2.21%		10 290
9 844
4.53%		15 269
15 192
0.51%		17 034
16 841
1.15%
EBITDA
Million CNY		Released
Forecast
Spread 		1 083
899
20.45%		1 671
1 427
17.07%		2 464
1 996
23.46%		4 590
4 150
10.59%		6 857
6 269
9.39%		6 993
5 939
17.75%
EBIT
Million CNY		Released
Forecast
Spread 		871
656
32.76%		1 156
1 038
11.39%		2 008
1 438
39.71%		3 327
3 382
-1.63%		4 609
5 129
-10.15%		4 253
4 644
-8.43%
Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread 		738
712
3.56%		1 127
1 139
-1.1%		1 966
1 682
16.85%		3 993
3 586
11.37%		5 358
5 448
-1.66%		4 174
4 491
-7.05%
Net income
Million CNY		Released
Forecast
Spread 		631
606
4.01%		1 010
999
1.14%		1 689
1 548
9.1%		3 388
3 060
10.75%		4 420
4 695
-5.86%		3 400
3 837
-11.39%
EPS
CNY		Released
Forecast
Spread 		0,16
0,16
0.47%		0,25
0,24
3.51%		0,40
0,42
-5.22%		0,77
0,74
4.43%		1,01
1,10
-8.1%		0,77
0,90
-14.26%
Announcement Date18/03/1926/03/2023/03/2122/03/2222/03/2326/03/24

Quarterly results

Fiscal PeriodDecember 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million CNY		Released
Forecast
Spread 		1 944
1 944
0.01%		3 668
3 579
2.48%		4 407
3 722
18.38%		5 883
5 573
5.58%		7 206
7 139
0.94%		8 062
7 926
1.72%		8 492
8 142
4.3%		8 542
8 390
1.82%
8 016


10 047

EBIT
Million CNY		Released
Forecast
Spread





1 773
1 298
36.59%		1 553
1 760
-11.74%		2 484
2 843
-12.64%		2 054
2 373
-13.45%		2 434
2 375
2.49%		1 819
1 899
-4.24%
2 108


2 583

Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread


1 261
720
75.2%








2 428
2 900
-16.29%		2 529
2 682
-5.71%		1 645
1 424
15.51%





Net income
Million CNY		Released
Forecast
Spread


953
480
98.39%


1 546
1 631
-5.19%


1 885
2 444
-22.86%		2 267
2 247
0.88%		1 133
1 082
4.72%





EPS
CNY		Released
Forecast
Spread

















0,52
0,41
26.83%








Announcement Date21/09/2023/03/2123/08/2122/03/2217/08/2222/03/2323/08/2326/03/24--

Upcoming sector events for WuXi Biologics (Cayman) Inc.

29/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
30/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
01/05/2024 01:35 am EXELIXIS, INC.: Q1 2024 Earnings Release
01/05/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for WuXi Biologics (Cayman) Inc.

26/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
26/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
26/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
26/04/2024 01:35 am PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 04:00 pm SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. Calendar WuXi Biologics (Cayman) Inc.